|
1
|
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
|
Ann Rheum Dis
|
2008
|
1.71
|
|
2
|
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
|
Ann Rheum Dis
|
2007
|
1.08
|
|
3
|
Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise.
|
Scand J Immunol
|
2007
|
0.89
|
|
4
|
Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.
|
Int J Biol Markers
|
2008
|
0.87
|
|
5
|
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
|
Ann Rheum Dis
|
2013
|
0.86
|
|
6
|
Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis.
|
Clin Exp Rheumatol
|
2009
|
0.78
|
|
7
|
Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
|
Scand J Rheumatol
|
2013
|
0.77
|
|
8
|
Circadian rhythm and the influence of physical activity on circulating surfactant protein D in early and long-standing rheumatoid arthritis.
|
Rheumatol Int
|
2010
|
0.76
|
|
9
|
Circadian pattern and the effect of standardized physical exercise on procollagen IIA N-peptide (PIIANP) in rheumatoid arthritis at different stages and in healthy individuals.
|
Biomarkers
|
2010
|
0.76
|
|
10
|
Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis.
|
Scand J Rheumatol
|
2014
|
0.76
|